In order to deliver Bcl-2 siRNA and CTND safely and simultaneously to the tumor cells and achieve a synergistic antitumor effect, CTND was linked to the carrier polymer PPF through an ATP-responsive boronate ester and then assembled with Bcl-2 siRNA to form the siRNA/CTND@PPF NP. The gene discussed is BCL2; the disease is neoplasm.